Ponatinib induces a sustained deep molecular response in a chronic myeloid leukaemia patient with an early relapse with a T315I mutation following allogeneic hematopoietic stem cell transplantation: a case report

Peer Review reports

Original Submission
15 Jun 2018	Submitted	Original manuscript
16 Aug 2018	Reviewed	Reviewer Report - Bjørn Tore Gjertsen
31 Aug 2018	Reviewed	Reviewer Report - Reviewer 2
8 Oct 2018	Author responded	Author comments - Nuno Cerveira
Resubmission - Version 2
8 Oct 2018	Submitted	Manuscript version 2
15 Oct 2018	Reviewed	Reviewer Report - Bjørn Tore Gjertsen
29 Oct 2018	Reviewed	Reviewer Report - Reviewer 2
14 Nov 2018	Author responded	Author comments - Nuno Cerveira
Resubmission - Version 3
14 Nov 2018	Submitted	Manuscript version 3
Publishing
16 Nov 2018	Editorially accepted
7 Dec 2018	Article published	10.1186/s12885-018-5100-4

Back to article page